Tarsus Pharmaceuticals, Inc. TARS Intangible Amortization
Intangible Amortization at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s intangible amortization?
- Tarsus Pharmaceuticals, Inc. (TARS) reported intangible amortization of $240K in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s intangible amortization changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s intangible amortization decreased by 0.0% year-over-year, from $240K to $240K.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s intangible amortization?
- Over 2 years (2023 to 2025), Tarsus Pharmaceuticals, Inc.'s intangible amortization has grown at a 196.8% compound annual growth rate (CAGR), from $100K to $881K.
- What does intangible amortization mean?
- Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.